miRagen Therapeutics Achieves First Milestone in Strategic Alliance with Servier

News   May 24, 2013

 
miRagen Therapeutics Achieves First Milestone in Strategic Alliance with Servier
 
 
 

RELATED ARTICLES

Sphere Fluidics and Geneva Biotech Receive Eurostars Genome Editing Grant

News

€1.6 million grant will support ‘precise docking of very large DNA cargoes in genomes’ project.

READ MORE

RNAi-based Drug Shows Promise as Treatment for Chronic Hepatitis B

News

The novel therapy by Arrowhead Pharmaceuticals uses a mechanism called RNA interference to reduce the surface antigens created by chronic HBV infections.

READ MORE

A More Effective Alternative to RNAi, CRISPR for Studying Protein Function

News

Trim-Away is a novel method enabling researchers to directly and rapidly destroy any protein in any kind of cell.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE